Insomnia disorder comprises symptoms during night and day that strongly affect quality of
life and wellbeing. Prolonged sleep latency, difficulties to maintain sleep and early morning …

Progress in the field of insomnia since 2017 necessitated this update of the European
Insomnia Guideline. Recommendations for the diagnostic procedure for insomnia and its …

Actigraphy has a consolidated role in Insomnia and Circadian Rhythm Sleep-Wake
Disorders (CRSWD) and recent studies have highlighted the use of actigraphy for …

Worldwide, the incidence of major depressive disorder (MDD) is increasing annually,
resulting in greater economic and social burdens. Moreover, the pathological mechanisms …

Rates of major depressive disorder (MDD) are increasing globally, in part due to the
coronavirus disease 2019 pandemic, contributing to disease burden. It has long been …

In the management of insomnia, physicians and patients are seeking alternative
therapeutics to sleeping pills, in addition to sleep hygiene and cognitive behavioural …

Introduction: The global disease burden of major depressive disorder urgently requires
prevention in high-risk individuals, such as recently discovered insomnia subtypes. Previous …

This systematic review (PROSPERO registration CRD42020158010) aimed to: 1) assess
how adherence to cognitive behavioural therapy for insomnia (CBT-I) has been measured; …

Hyperarousal, recognized as a fundamental characteristic of insomnia for decades, has
yielded limited evidence concerning its direct psychological associations. This study aimed …

Together with (physical and mental) exercise, diet, and social activities, sleep is a key health
behavior that occupies one third of our lives, yet remains neglected. In the first part of this …